Semaglutide injection volume calculator
Work out the syringe reading for Semaglutide from your own numbers. Nothing is pre-filled: this page does arithmetic only and does not recommend any dose.
FDA-approved · Reviewed
How Semaglutide is supplied
Brand-name pens (Ozempic, Wegovy) are pre-measured, so there is nothing to calculate. Compounded semaglutide is dispensed as a liquid vial labeled in mg per mL, which is what this calculator is for.
The arithmetic
Volume to draw = dose ÷ concentration. A vial labeled 2.5 mg per mL holds 0.25 mg in every 0.1 mL. On a U-100 insulin syringe, 0.1 mL is 10 units. Oils are usually drawn with a syringe marked in mL, so the result is shown in mL when that syringe is chosen.
Before you draw
Approved in several forms. Ozempic injection is approved for type 2 diabetes. Wegovy injection is approved for chronic weight management, and a higher-strength version, Wegovy HD, was approved in March 2026. A Wegovy pill was approved in December 2025 for weight management and for lowering cardiovascular risk. Oral tablets for type 2 diabetes are sold as Rybelsus and, since February 2026, under the Ozempic name.
Read the full Semaglutide profile for its regulatory status, the evidence and the known risks.
How do I convert a Semaglutide dose in mg to mL?
Divide the dose by the concentration printed on the vial label. Enter both above to see the volume and the syringe reading.
Which syringe should I use?
Use the syringe your pharmacy or prescriber supplies. Insulin syringes are marked in units; others are marked in mL. Choose the matching option above.
Does this page recommend a dose?
No. It only does arithmetic on the numbers you enter. Doses come from a prescriber or product label.
Sources: Managed Healthcare Executive: GLP-1 pills; Prime Therapeutics: GLP-1 pipeline update, August 2026; Novo Nordisk: Wegovy and Saxenda safety information; Polsinelli: FDA compounded GLP-1 policy.
For research and educational use. Not medical advice. Confirm every calculation and dose with a licensed professional.